AstraZeneca will no longer invest 450 million pounds ($558.3 million) at its vaccine manufacturing plant in northern England, ...
The green light from the European Medicines Agency is the first backing in the EU for the medicine, following its approval in ...
AstraZeneca (AZN) stock in focus as its partner Daiichi Sankyo (DSNKY) wins EU backing for their jointly developed breast ...
AstraZeneca cancels £450m investment in UK after dispute over Government support - The pharmaceutical giant claimed the ...
All nine macaques given the control developed severe disease when exposed to bird flu, as did all given the smallest dose of ...
AstraZeneca invests $570 million in Canada, expands facilities, and boosts R&D efforts, aiming to deliver 20 new medicines ...
In a report released yesterday, Seamus Fernandez from Guggenheim reiterated a Buy rating on AstraZeneca (AZN – Research Report), with a price ...
Several factors have influenced this decision including the timing and reduction of the final offer compared to the previous government’s proposal' ...
The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...